0
0
London, July 11 — A pioneering study from Sheffield Hallam University has unveiled a promising new approach to preventing hair loss in cancer patients undergoing chemotherapy, potentially transforming one of the most distressing side effects of cancer treatment into a manageable concern.
The research, led by Dr. Nik Georgopoulos and published in Frontiers in Pharmacology, demonstrates that combining scalp cooling with a topical antioxidant-rich treatment can dramatically reduce damage to hair follicles caused by chemotherapy drugs. Scalp cooling, already used in some cancer clinics via “cold caps,” works by slowing blood flow to the scalp, thereby limiting the exposure of hair follicles to toxic agents.
The Sheffield Hallam team identified 18°C as the optimal scalp temperature for protecting follicles. Notably, when this cooling was paired with antioxidant lotions—containing compounds similar to those found in red grapes—the protective effect was significantly enhanced. Even at less-than-ideal cooling temperatures, the addition of antioxidants such as N-acetylcysteine or resveratrol provided robust protection, nearly matching the results seen at optimal cooling alone.
“Our findings suggest that the combination of cooling and antioxidants could be a game-changer in preventing chemotherapy-induced hair loss and could make a real difference to the lives of cancer patients worldwide,” said Dr. Georgopoulos, Associate Professor of Cell Biology at Sheffield Hallam University.
The study involved isolating and growing human scalp follicles in laboratory settings, then exposing them to chemotherapy agents. The dual therapy was shown to shield these follicles from the cellular damage typically caused by treatment. Researchers believe this approach could standardize and improve the effectiveness of scalp cooling, making it more accessible and reliable for a broader range of patients.
Hair loss affects approximately 65% of chemotherapy patients, with nearly half of female patients describing it as the most traumatic part of their treatment. Preserving hair is not merely a cosmetic concern; for many, it is closely tied to identity, confidence, and a sense of normalcy during a challenging period.
The next steps include clinical trials to test the efficacy and safety of this combined therapy in patients, with hopes that it will soon become a standard part of supportive cancer care.
Disclaimer: The findings described are based on laboratory research and have not yet been validated in large-scale clinical trials. Patients should consult their healthcare providers before considering any new treatments. This article is for informational purposes only and does not constitute medical advice.
